Skip to search formSkip to main contentSkip to account menu

ISCOMATRIX

National Institutes of Health

Related topics

Related topics

5 relations

Broader (5)

CholesterolDrug CombinationsPhospholipidsSaponins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The role of surface charge of ISCOMATRIX nanoparticles on the type of immune response generated against Leishmaniasis in BALB/c mice
Objective(s): It is proposed that particulate antigens could better interact with the antigen presenting cells (APCs). A fast… 
2014
2014
Reduced MyD88 dependency of ISCOMATRIX™ adjuvant in a DNA prime-protein boost HIV vaccine
ISCOMATRIX™ adjuvant is an integrated adjuvant system due to its ability to both facilitate antigen delivery and immunomodulate… 
2013
2013
CpG ODN and ISCOMATRIX Adjuvant: A Synergistic Adjuvant Combination Inducing Strong T-Cell IFN-γ Responses
For the induction of robust humoral and cellular immune responses, a strong rationale exists to use vaccine-adjuvant combinations… 
Review
2013
Review
2013
New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.
2012
2012
Improved immune response to recombinant influenza nucleoprotein formulated with ISCOMATRIX.
Current influenza vaccines elicit antibodies effective against homologous strains, but new strategies are urgently needed for… 
2012
2012
Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex
Antibodies that neutralize infectivity of malaria sporozoites target the central repeat region of the circumsporozoite (CS… 
2011
2011
Evaluating functional antibodies in rhesus monkeys immunized with hepatitis B virus surface antigen vaccine with novel adjuvant formulations.
2007
2007
Immune response of BALB/c mouse immunized with recombinant MSPs proteins of Anaplasma marginale binding to immunostimulant complex (ISCOM).
Review
2006
Review
2006
Ii-Key/MHC class II epitope hybrids: a strategy that enhances MHC class II epitope loading to create more potent peptide vaccines
Life-threatening diseases, such as cancer and pandemic influenza, demand new efforts towards effective vaccine design. Peptides… 
1997
1997
Influence of Quillaja saponaria Triterpenoid Content on the Immunomodulatory Capacity of Epstein–Barr Virus Iscoms
The immune responses to immunostimulating complexes (iscoms) containing recombinant Epstein–Barr virus (EBV) gp340 envelope… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)